News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Elastagen Stretches Commercial Wings
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
New Sydney University spinoff Elastagen is courting potential investors and commercial collaborators to develop organ-and-tissue-engineering applications for its super-stretchy protein, tropoelastin.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Australia
MORE ON THIS TOPIC
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
August 24, 2026
·
1 min read
·
Tristan Manalac
Duchenne muscular dystrophy
Capricor investor calls for change as company awaits decision on Duchenne candidate
August 21, 2026
·
3 min read
·
Heather McKenzie
Policy
Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths
August 21, 2026
·
4 min read
·
Gabrielle Masson
Deals
Werewolf and Ambros to tie the knot in $150M rare disease deal
August 21, 2026
·
2 min read
·
Michael Gibney